1. Scrip

NiKem gets GLP certification

 
• By James Mills

The Italian government has certified NiKem Research's bioanalysis facilities, allowing it to support its clients' preclinical pharmacokinetics and toxicology studies. The company was already offering hit validation and multiparametric lead optimisation services, along with other services related to drug discovery.

The Italian government has certified NiKem Research's bioanalysis facilities, allowing it to support its clients' preclinical pharmacokinetics and toxicology studies. The company was already offering hit validation and multiparametric lead optimisation services, along with other services related to drug discovery.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Scrip

KalVista’s Delayed FDA Approval In HAE Comes Through

 
• By Joseph Haas

KalVista’s Ekterly obtains US approval as the first oral, on-demand therapy for hereditary angioedema. It will compete with established injectables.

Cogent Peaks With Bezaclastinib SUMMIT Results

 
• By Alaric DeArment

The biotech announced positive topline results from the Phase II SUMMIT study in non-advanced systemic mastocytosis, with data for advanced SM and GIST expected later this year.

France’s AB Science Plots Pivotal Masitinib Trial In Prostate Cancer

 
• By Kevin Grogan

Still holding out hope after multiple rejections for the tyrosine kinase inhibitor.